Skip to main content
. Author manuscript; available in PMC: 2024 Nov 18.
Published in final edited form as: Urol Oncol. 2021 Mar 4;39(10):731.e17–731.e24. doi: 10.1016/j.urolonc.2021.02.008

Table 2.

End-of-life care measures

Characteristic Total cohort (n = 6,066) Any high-intensity end-of-life care (n = 2,728)

Any high-intensity end-of-life care (%) 2,728 (45.0) 2,728 (100.0)
Multiple admissions (%) 819 (13.5) 819 (30.0)
Multiple Emergency Department visits (%) 991 (16.3) 991 (36.3)
Intensive Care Unit admission (%) 1,367 (22.5) 1,367 (50.1)
Chemotherapy near EoL (%) 152 (2.5) 152 (5.6)
In-hospital death (%) 1,463 (24.1) 1,463 (53.6)
Number of high-intensity end of life measures (%)
 0 3,338 (55.0) 0 (0)
 1 1,281 (21.1) 1,281 (47.0)
 2 952 (15.7) 952 (34.9)
 3 or more 495 (8.2) 495 (18.1)